South Berwick Pharmacy Seacoast Compounding, Inc.

Form 483 issued September 30, 2022 · South Berwick, Maine

Inspection
Sep 12 – Sep 30, 2022
Observations
4
Pages
4
FEI number
3005636572

In short: On September 30, 2022, FDA issued a Form 483 with 4 observations to South Berwick Pharmacy Seacoast Compounding, Inc. in South Berwick, Maine (FEI 3005636572) after an inspection that ran Sep 12 – Sep 30, 2022. The investigators were Daniel L. Zheng and Erik W. Koester.

What FDA observed

Preview: the opening words of each observation
  1. 01
    FDCA 501(a)(2)(A)

    You produced hazardous drug; without providing adequate containment, segregation, cleaning of work surfaces and cleaning of…

  2. 02
    FDCA 501(a)(2)(A)

    Non-microbial contamination was observed…

  3. 03
    FDCA 501(a)(2)(A)

    Vermin was observed in…

  4. 04
    FDCA 501(a)(2)(A)

    You used a non-pharmaceutical grade component in the formulation…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at South Berwick Pharmacy Seacoast Compounding, Inc.?

FDA listed 4 observations on this Form 483. The opening words of each observation are shown on this page.

Who inspected South Berwick Pharmacy Seacoast Compounding, Inc.?

Daniel L. Zheng and Erik W. Koester are named on this Form 483, for the inspection of Sep 12 – Sep 30, 2022. Each investigator has a profile showing what they cite most.

When was South Berwick Pharmacy Seacoast Compounding, Inc. inspected by FDA?

The inspection ran Sep 12 – Sep 30, 2022, and the Form 483 is dated September 30, 2022.

How do I get the full Form 483 for South Berwick Pharmacy Seacoast Compounding, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free